v3.26.3
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock
Additional Paid-in- Capital
Treasury Stock
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Beginning balance at Dec. 28, 2024 $ 6 $ 325,601 $ (11,912) $ 1,055 $ (229,575) $ 85,175
Beginning balance (in shares) at Dec. 28, 2024 5,745          
Increase (Decrease) in Stockholders' Equity            
Net loss         (15,283) (15,283)
Issuance of shares in connection with restricted stock units vesting   (396)       (396)
Issuance of shares in connection with restricted stock units vesting (in shares) 72          
Issuance of shares in connection with BOD fees   11       11
Issuance of shares in connection with BOD fees (in shares) 1          
Issuance of shares in connection with ESPP   96       96
Issuance of shares in connection with ESPP (in shares) 11          
Share-based compensation   3,166       3,166
Ending balance at Mar. 29, 2025 $ 6 328,479 (11,912) 1,055 (244,858) 72,770
Ending balance (in shares) at Mar. 29, 2025 5,829          
Beginning balance at Dec. 28, 2024 $ 6 325,601 (11,912) 1,055 (229,575) 85,175
Beginning balance (in shares) at Dec. 28, 2024 5,745          
Increase (Decrease) in Stockholders' Equity            
Net loss           (38,879)
Ending balance at Sep. 27, 2025 $ 7 343,461 (11,912) 1,055 (268,454) 64,156
Ending balance (in shares) at Sep. 27, 2025 6,935          
Beginning balance at Mar. 29, 2025 $ 6 328,479 (11,912) 1,055 (244,858) 72,770
Beginning balance (in shares) at Mar. 29, 2025 5,829          
Increase (Decrease) in Stockholders' Equity            
Net loss         (12,711) (12,711)
Issuance of shares in connection with restricted stock units vesting   (69)       (69)
Issuance of shares in connection with restricted stock units vesting (in shares) 45          
Issuance of shares in connection with BOD fees   14       14
Issuance of shares in connection with BOD fees (in shares) 2          
Share-based compensation   2,441       2,441
Ending balance at Jun. 28, 2025 $ 6 330,866 (11,912) 1,055 (257,569) 62,445
Ending balance (in shares) at Jun. 28, 2025 5,876          
Increase (Decrease) in Stockholders' Equity            
Net loss         (10,885) (10,885)
Issuance of shares in connection with restricted stock units vesting   (53)       (53)
Issuance of shares in connection with restricted stock units vesting (in shares) 16          
Issuance of shares in connection with BOD fees   15       15
Issuance of shares in connection with BOD fees (in shares) 2          
Issuance of shares in connection with ESPP   57       57
Issuance of shares in connection with ESPP (in shares) 9          
Issuance of shares in connection with equity purchase agreement $ 1 10,732       10,733
Issuance of shares in connection with equity purchase agreement (in shares) 1,032          
Issuance costs in connection with equity purchase agreement   (383)       (383)
Share-based compensation   2,227       2,227
Ending balance at Sep. 27, 2025 $ 7 343,461 (11,912) 1,055 (268,454) 64,156
Ending balance (in shares) at Sep. 27, 2025 6,935          
Beginning balance at Jan. 03, 2026 $ 7 344,176 (11,912) 1,223 (280,018) 53,476
Beginning balance (in shares) at Jan. 03, 2026 7,005          
Increase (Decrease) in Stockholders' Equity            
Net loss         (1,940) (1,940)
Issuance of shares in connection with restricted stock units vesting   (77)       (77)
Issuance of shares in connection with restricted stock units vesting (in shares) 41          
Issuance of shares in connection with BOD fees   12       12
Issuance of shares in connection with BOD fees (in shares) 2          
Issuance of shares in connection with equity purchase agreement $ 1 7,999       8,000
Issuance of shares in connection with equity purchase agreement (in shares) 1,000          
Issuance costs in connection with equity purchase agreement   (36)       (36)
Share-based compensation   1,395       1,395
Deconsolidation from the sale of subsidiary       (1,223)   (1,223)
Ending balance at Apr. 04, 2026 $ 8 353,468 (11,912)   (281,958) 59,606
Ending balance (in shares) at Apr. 04, 2026 8,048          
Beginning balance at Jan. 03, 2026 $ 7 344,176 (11,912) $ 1,223 (280,018) 53,476
Beginning balance (in shares) at Jan. 03, 2026 7,005          
Increase (Decrease) in Stockholders' Equity            
Net loss           (9,269)
Ending balance at Oct. 03, 2026 $ 8 354,695 (11,912)   (289,287) 53,504
Ending balance (in shares) at Oct. 03, 2026 8,070          
Beginning balance at Apr. 04, 2026 $ 8 353,468 (11,912)   (281,958) 59,606
Beginning balance (in shares) at Apr. 04, 2026 8,048          
Increase (Decrease) in Stockholders' Equity            
Net loss         (3,222) (3,222)
Issuance of shares in connection with restricted stock units vesting   (51)       (51)
Issuance of shares in connection with restricted stock units vesting (in shares) 9          
Issuance of shares in connection with BOD fees   12       12
Issuance of shares in connection with BOD fees (in shares) 1          
Issuance costs in connection with equity purchase agreement   (19)       (19)
Share-based compensation   466       466
Ending balance at Jul. 04, 2026 $ 8 353,876 (11,912)   (285,180) 56,792
Ending balance (in shares) at Jul. 04, 2026 8,058          
Increase (Decrease) in Stockholders' Equity            
Net loss         (4,107) (4,107)
Issuance of shares in connection with restricted stock units vesting   (30)       (30)
Issuance of shares in connection with restricted stock units vesting (in shares) 10          
Issuance of shares in connection with BOD fees   12       12
Issuance of shares in connection with BOD fees (in shares) 2          
Share-based compensation   837       837
Ending balance at Oct. 03, 2026 $ 8 $ 354,695 $ (11,912)   $ (289,287) $ 53,504
Ending balance (in shares) at Oct. 03, 2026 8,070